TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
ALVO

Alvotech

Healthcare · Drug Manufacturers - Specialty & Generic

5.80$ -2.0% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Alvotech (ALVO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,587 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ALVO
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
959 950 1,061 1,068 1,233 1,221 1,245 1,393 1,409 1,487 1,421 1,587
228 195 292 285 433 455 459 509 432 574 456 545
68 11 65 11 118 51 39 151 43 172 64 143
68 11 65 11 118 51 39 151 43 172 64 143
42 87 72 156 146 252 229 180 122 154 107 115
82 74 92 97 125 128 142 155 208 220 228 227
12 12 12 12 12 11 11 13 13 13 13 12
20 19 19 20 21 21 22 55 62 82 120 142
1,620 1,883 1,719 1,674 1,577 1,634 1,548 1,566 1,586 1,772 1,703 1,779
187 261 247 1,202 161 193 266 280 304 304 260 331
22 48 49 1,010 34 42 44 60 56 49 56 54
53 81 50 59 58 67 68 84 92 126 98 133
898 922 941 57 1,006 1,036 1,064 1,072 1,082 1,262 1,267 1,264
-661 -932 -659 -606 -344 -413 -302 -173 -177 -284 -282 -191
-1,929 -2,206 -2,425 -2,359 -2,371 -2,438 -2,328 -2,296 -2,301 -2,410 -2,409 -2,476
267 267 267 259 280 302 313 313 300 279 330 357

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?